Literature DB >> 25935149

Bone microenvironment signals in osteosarcoma development.

Arantzazu Alfranca1, Lucia Martinez-Cruzado, Juan Tornin, Ander Abarrategi, Teresa Amaral, Enrique de Alava, Pablo Menendez, Javier Garcia-Castro, Rene Rodriguez.   

Abstract

The bone is a complex connective tissue composed of many different cell types such as osteoblasts, osteoclasts, chondrocytes, mesenchymal stem/progenitor cells, hematopoietic cells and endothelial cells, among others. The interaction between them is finely balanced through the processes of bone formation and bone remodeling, which regulates the production and biological activity of many soluble factors and extracellular matrix components needed to maintain the bone homeostasis in terms of cell proliferation, differentiation and apoptosis. Osteosarcoma (OS) emerges in this complex environment as a result of poorly defined oncogenic events arising in osteogenic lineage precursors. Increasing evidence supports that similar to normal development, the bone microenvironment (BME) underlies OS initiation and progression. Here, we recapitulate the physiological processes that regulate bone homeostasis and review the current knowledge about how OS cells and BME communicate and interact, describing how these interactions affect OS cell growth, metastasis, cancer stem cell fate and therapy outcome.

Entities:  

Mesh:

Year:  2015        PMID: 25935149     DOI: 10.1007/s00018-015-1918-y

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  157 in total

1.  Therapeutic relevance of osteoprotegerin gene therapy in osteosarcoma: blockade of the vicious cycle between tumor cell proliferation and bone resorption.

Authors:  Francois Lamoureux; Peggy Richard; Yohann Wittrant; Séverine Battaglia; Paul Pilet; Valérie Trichet; Frédéric Blanchard; Francois Gouin; Bruno Pitard; Dominique Heymann; Francoise Redini
Journal:  Cancer Res       Date:  2007-08-01       Impact factor: 12.701

2.  Vasculogenic mimicry: a new prognostic sign of human osteosarcoma.

Authors:  Ke Ren; Nan Yao; Guangye Wang; Lei Tian; Jie Ma; Xin Shi; Lei Zhang; Jian Zhang; Xing Zhou; Guangxin Zhou; Sujia Wu; Xiaoliang Sun
Journal:  Hum Pathol       Date:  2014-06-30       Impact factor: 3.466

3.  Cyr61 expression in osteosarcoma indicates poor prognosis and promotes intratibial growth and lung metastasis in mice.

Authors:  Adam A Sabile; Matthias J E Arlt; Roman Muff; Beata Bode; Bettina Langsam; Josefine Bertz; Thorsten Jentzsch; Gabor J Puskas; Walter Born; Bruno Fuchs
Journal:  J Bone Miner Res       Date:  2012-01       Impact factor: 6.741

4.  Fibroblast growth factor-2 is an important factor that maintains cellular immaturity and contributes to aggressiveness of osteosarcoma.

Authors:  Takatsune Shimizu; Tomoki Ishikawa; Sayaka Iwai; Arisa Ueki; Eiji Sugihara; Nobuyuki Onishi; Shinji Kuninaka; Takeshi Miyamoto; Yoshiaki Toyama; Hiroshi Ijiri; Hajime Mori; Yumi Matsuzaki; Tomonori Yaguchi; Hiroshi Nishio; Yutaka Kawakami; Yasuo Ikeda; Hideyuki Saya
Journal:  Mol Cancer Res       Date:  2012-01-06       Impact factor: 5.852

5.  Expression of transforming growth factor beta isoforms in osteosarcoma variants: association of TGF beta 1 with high-grade osteosarcomas.

Authors:  A Franchi; L Arganini; G Baroni; A Calzolari; R Capanna; D Campanacci; P Caldora; L Masi; M L Brandi; G Zampi
Journal:  J Pathol       Date:  1998-07       Impact factor: 7.996

6.  The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis.

Authors:  Chand Khanna; Xiaolin Wan; Seuli Bose; Ryan Cassaday; Osarenoma Olomu; Arnulfo Mendoza; Choh Yeung; Richard Gorlick; Stephen M Hewitt; Lee J Helman
Journal:  Nat Med       Date:  2004-01-04       Impact factor: 53.440

Review 7.  Cells of origin in osteosarcoma: mesenchymal stem cells or osteoblast committed cells?

Authors:  Anthony J Mutsaers; Carl R Walkley
Journal:  Bone       Date:  2014-02-14       Impact factor: 4.398

8.  Anti-TGF-β antibody combined with dendritic cells produce antitumor effects in osteosarcoma.

Authors:  Masanori Kawano; Ichiro Itonaga; Tatsuya Iwasaki; Hiroyuki Tsuchiya; Hiroshi Tsumura
Journal:  Clin Orthop Relat Res       Date:  2012-03-14       Impact factor: 4.176

9.  Wnt5a promotes migration of human osteosarcoma cells by triggering a phosphatidylinositol-3 kinase/Akt signals.

Authors:  Ailiang Zhang; Shuanghua He; Xiaoliang Sun; Lianghua Ding; Xinnan Bao; Neng Wang
Journal:  Cancer Cell Int       Date:  2014-02-14       Impact factor: 5.722

10.  The genetic basis for inactivation of Wnt pathway in human osteosarcoma.

Authors:  Xiaoling Du; Jilong Yang; Da Yang; Wei Tian; Ze Zhu
Journal:  BMC Cancer       Date:  2014-06-18       Impact factor: 4.430

View more
  60 in total

1.  Synergistic antitumor effect of suberoylanilide hydroxamic acid and cisplatin in osteosarcoma cells.

Authors:  Mengyi Hou; Zhenglan Huang; Sicheng Chen; Hao Wang; Tianyu Feng; Shujuan Yan; Yuxi Su; Guowei Zuo
Journal:  Oncol Lett       Date:  2018-07-27       Impact factor: 2.967

2.  TET2-dependent IL-6 induction mediated by the tumor microenvironment promotes tumor metastasis in osteosarcoma.

Authors:  Hitoshi Itoh; Tsuyoshi Kadomatsu; Hironori Tanoue; Masaki Yugami; Keishi Miyata; Motoyoshi Endo; Jun Morinaga; Eisuke Kobayashi; Takeshi Miyamoto; Ryoma Kurahashi; Kazutoyo Terada; Hiroshi Mizuta; Yuichi Oike
Journal:  Oncogene       Date:  2018-03-08       Impact factor: 9.867

3.  Macrophage-derived CCL18 promotes osteosarcoma proliferation and migration by upregulating the expression of UCA1.

Authors:  Yang Su; Yan Zhou; Yuan-Jue Sun; Ya-Ling Wang; Jun-Yi Yin; Yu-Jing Huang; Jian-Jun Zhang; Ai-Na He; Kun Han; Hui-Zhen Zhang; Yang Yao; Xiao-Bin Lv; Hai-Yan Hu
Journal:  J Mol Med (Berl)       Date:  2018-11-13       Impact factor: 4.599

4.  Modeling the Tumor Microenvironment and Pathogenic Signaling in Bone Sarcoma.

Authors:  Eric R Molina; Letitia K Chim; Sergio Barrios; Joseph A Ludwig; Antonios G Mikos
Journal:  Tissue Eng Part B Rev       Date:  2020-02-14       Impact factor: 6.389

5.  Long non-coding RNA AK093407 promotes proliferation and inhibits apoptosis of human osteosarcoma cells via STAT3 activation.

Authors:  Yongkun Wang; Tingting Liang; Yao Wang; Yan Huang; Ye Li
Journal:  Am J Cancer Res       Date:  2017-04-01       Impact factor: 6.166

6.  Bone microenvironment has an influence on the histological response of osteosarcoma to chemotherapy: retrospective analysis and preclinical modeling.

Authors:  Vincent Crenn; Kevin Biteau; Jérôme Amiaud; Clotilde Dumars; Romain Guiho; Luciano Vidal; Louis-Romée Le Nail; Dominique Heymann; Anne Moreau; François Gouin; Françoise Redini
Journal:  Am J Cancer Res       Date:  2017-11-01       Impact factor: 6.166

7.  Mechanically tunable coaxial electrospun models of YAP/TAZ mechanoresponse and IGF-1R activation in osteosarcoma.

Authors:  Eric R Molina; Letitia K Chim; Maria C Salazar; Shail M Mehta; Brian A Menegaz; Salah-Eddine Lamhamedi-Cherradi; Tejus Satish; Sana Mohiuddin; David McCall; Ana Maria Zaske; Branko Cuglievan; Alexander J Lazar; David W Scott; Jane K Grande-Allen; Joseph A Ludwig; Antonios G Mikos
Journal:  Acta Biomater       Date:  2019-09-19       Impact factor: 8.947

8.  Knockdown of Sox2 Inhibits OS Cells Invasion and Migration via Modulating Wnt/β-Catenin Signaling Pathway.

Authors:  Liang Tang; Dong Wang; Dongyun Gu
Journal:  Pathol Oncol Res       Date:  2018-04-04       Impact factor: 3.201

Review 9.  Tissue-engineered 3D models for elucidating primary and metastatic bone cancer progression.

Authors:  Eva C González Díaz; Sauradeep Sinha; Raffi S Avedian; Fan Yang
Journal:  Acta Biomater       Date:  2019-08-13       Impact factor: 8.947

10.  Prediction of neoadjuvant chemotherapy response in high-grade osteosarcoma: added value of non-tumorous bone radiomics using CT images.

Authors:  Lei Xu; Pengfei Yang; Kun Hu; Yan Wu; Meng Xu-Welliver; Yidong Wan; Chen Luo; Jing Wang; Jinhua Wang; Jiale Qin; Yi Rong; Tianye Niu
Journal:  Quant Imaging Med Surg       Date:  2021-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.